MedPath

Clinical Efficacy of Angulated Screw-retained and Cemented Single Implant Crowns in Esthetic Region

Not Applicable
Completed
Conditions
Angulated Screw-retained
Esthetics
Registration Number
NCT04539912
Lead Sponsor
Junyu Shi
Brief Summary

Objective: To compare the clinical efficacy of angulated screw-retained and cemented single implant crowns(SIC) in esthetic region.

Methods/Design: The study was a prospective, single center, randomized controlled clinical trial. Patients with the needs of single tooth restoration in esthetics region were recruited from Oct. 2018 to Aug. 2019. Sixty patients were enrolled in the present study and they were randomly assigned into two groups: angulated screw-retained group(AG, 30 patients) and cemented group (CG,30 patients). Clinical and radiological evaluations were performed on the day of final crowns delivery and 12 months later. Implant survival rate, marginal bone loss(MBL), pro-inflammatory cytokinesin peri-implant crevicular fluid (PICF)(TNF-α, IL-6), mechanical complications, peri-implant conditions(mPI, PD, BOP%), pink esthetics score/white esthetics score (PES/ WES) and patients satisfaction were assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
    1. age≥18;
    1. Single dental implant in the esthetic region;
    1. adjacent to natural teeth;
    1. absence of oral mucosal disease and oral infection;
  • 5)implants withconical connection (Nobel Active, Nobel Biocare® or NobelReplace Conical Connection, Nobel Biocare®);
  • 6)patients with the willingness of all-ceramic permanent restorations.
Exclusion Criteria
  • 1)Multiple implants in the esthetic region, or the restoration is a bridge;
  • 2)Heavy smokers (>10 cigarettes/day);
    1. the angle between implant axis and restoration axis>25°;
    1. uncontrolled periodontitis;
    1. with systematic diseases that may affect implant therapy, such as uncontrolled diabetes mellitus (Fasting blood-glucose>7.2mmol/L, Glycosylated hemoglobin >7%), current intake of bisphosphonates (treatment for malignancy), pregnant(or plan to get pregnant), with history of radiation therapy in head and neck region;
    1. Unwilling to participate in the present study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Marginal bone loss1year

Peri-apical radiographs with paralleling technique wereperformed on the day offinal restorations delivery and 1-year visit. Implant length was used as calibration reference. The distance between restoration margin and the most coronal level of implant-bone contactwas recorded. Final result was calculated as themean value of the mesial and distal sites

Secondary Outcome Measures
NameTimeMethod
Mechanical complications1 year

Abutments or implants fracture and screw loosening or fracture

PES/WES1 year

specific dentists were asked to give scores for variables of PES (Mesial papilla, distal papilla, level of soft-tissue margin, soft-tissue contour, alveolar process and soft-tissue color and texture) and WES (Tooth form, tooth volume/outline, color, surface texture and transparency) with the 2-1-0 scoring system. Final PES/WES was the sum the two. Total scores were defined as perfect rate (PES/WES≥22), acceptable rate (22\>PES/WES≥15) and unfavorable rate (PES/WES\<15).

Patient's satisfaction1 year

patient's satisfaction(PS) with aesthetics, function and comfort of the restoration at 1-year visit. 0 score was extremely dissatisfied and 10 score was extremely satisfied. We also defined the final scores as perfect rate(PS≥9), acceptable rate(9\>PS≥6) and unfavorable rate (PS\<6).

Pro-inflammatory cytokinesin peri-implant crevicular fluid (PICF)1 year

we collected the patients' PICF with the paper strip (PerioPaper Strips; Oraflow Inc., Smithtown, NY, USA) at 1year follow-up to access differences in pro-inflammatory cytokines (IL-6 and TNF-α) between two groups.

pocket probing depth(PD)1 year

The depth of 6 sites(mesial, middle and distal of buccal/lingual ) was measured and the average value was calculated.

modified plaque index (mPI)1 year

Score 0; No detection of plaque Score 1: Plaque only recognized by running a probe across the smooth marginal surface of the implant. Implants covered by titanium spray in this area always score 1.

Score 2: Plaque can be seen by the naked eye. Score 3: Abundance of soft matter.

Survival rate.1 year

Survival rates were defined as the percentage of success implants and remained crowns which never been replaced

bleeding on probing% (BOP%)1 year

The BOP of 6 sites(mesial, middle and distal of buccal/lingual ) was probed and the percentage of BOP(+) was calculated.

Trial Locations

Locations (1)

Jun-Yu Shi

🇨🇳

Shanghai, Shanghai, China

Jun-Yu Shi
🇨🇳Shanghai, Shanghai, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.